Todas as matérias desta seção, das mais recentes às mais antigas — página 253 de 371.
Olema Oncology (NASDAQ:OLMA) announced its fourth-quarter and full-year 2025 financial results on Monday, highlighting a year of substantial capital formation and clinical acceleration.
Relay Therapeutics (NASDAQ:RLAY) announced clinical data from its Phase 1/2 ReDiscover trial on Monday, providing a significant update on the efficacy and safety of zovegalisib (formerly RLY-2608).
Telos (NASDAQ:TLS) reported its fourth-quarter and full-year 2025 financial results on March 16, 2026, delivering a "beat and raise" performance that underscores the company’s successful pivot toward higher-margin security software.
Canopy Growth (NASDAQ:CGC) and MTL Cannabis announced the successful closing of their previously disclosed arrangement on Monday.
Annovis Bio (NYSE:ANVS) reported its full-year 2025 financial results and clinical milestones on March 16, 2026, highlighting a period of aggressive execution for its neurodegenerative disease pipeline.
Nasus Pharma (NYSE:NSRX) announced positive topline results from its Phase 2 clinical study of NS002, a proprietary intranasal epinephrine powder designed to treat life-threatening allergic reactions.
Nebius (NASDAQ:NBIS) shares surged 13% to $128.08 in premarket trading on Monday following the announcement of a landmark five-year agreement with Meta Platforms (NASDAQ:META).
Agenus (NASDAQ:AGEN) reported its financial results for the fourth quarter and full year ended December 31, 2025, marking a transition from a purely clinical-stage company to one generating initial pre-commercial revenue.
Bitdeer Technologies Group (NASDAQ:BTDR) released its unaudited mining and operations update for February 2026, highlighting its position as a dominant force in the global digital asset and AI infrastructure landscape.
Meta Platforms (NASDAQ:META) shares rose 3% in premarket trading on Monday following reports that the company is considering laying off at least 20% of its workforce.
Tilray Brands (NASDAQ:TLRY) on Monday announced it has entered into an asset purchase agreement to acquire key BrewDog operating assets in the United States, including the Columbus, Ohio brewery, three Ohio pubs, a Columbus hotel, the Las Vegas flagship brewpub, a franchised Denver location and a licensed site at Columbus airport.
CytomX Therapeutics (NASDAQ:CTMX) reported its full-year 2025 financial results and a strategic business update on March 16, 2026, highlighting the continued evolution of its Probody® platform.
Science Applications International Corp. (NASDAQ:SAIC) reported its fiscal fourth quarter and full-year 2026 results on March 16, 2026, showcasing a company in the midst of a significant structural and leadership transition.
OPAL Fuels (NASDAQ:OPAL) announced its fourth-quarter and full-year 2025 financial results on Monday, highlighting a year of robust operational growth and strategic capital management.
WW International (NASDAQ:WW) reported its fourth-quarter and full-year 2025 results on March 16, 2026, signaling a successful stabilization of its business model following a major financial restructuring mid-year.
Eli Lilly and Company (NYSE:LLY) on Monday announced positive topline results from the Phase 3 ADorable-1 trial evaluating EBGLYSS (lebrikizumab-lbkz) in patients aged six months to 18 years with moderate-to-severe atopic dermatitis.
Forgent Power Solutions (NYSE:FPS) reported explosive growth for its fiscal second quarter ended December 31, 2025, as the recently public company capitalizes on the massive infrastructure buildout required for artificial intelligence and grid modernization.
Dollar Tree (NASDAQ:DLTR) reported robust financial results for its fourth quarter and full fiscal year ended January 31, 2026, underscored by the continued expansion of its "Dollar Tree 3.0" multi-price strategy.
Alto Neuroscience (NYSE:ANRO) reported its full-year 2025 financial results, highlighting a strengthened balance sheet and a disciplined approach to research and development.
Townsquare Media (NYSE:TSQ) announced its fourth-quarter and full-year 2025 financial results on March 16, 2026, marking a significant structural pivot for the Purchase, New York-based company.
KE Holdings (NYSE:BEKE), the leading integrated online and offline platform for housing transactions and services in China, reported its unaudited financial results for the fourth quarter and full year 2025.
WaterBridge Infrastructure (NYSE:WBI) reported its full-year 2025 financial results on Monday, highlighting a transformative year defined by its September initial public offering and the strategic combination of its legacy operating entities.
VNET Group (NASDAQ:VNET) reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025, on March 16, 2026.
Niu Technologies (NASDAQ:NIU) reported its unaudited financial results for the fourth quarter and full year 2025 on March 16, 2026, revealing a year of starkly different halves.
